| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.16 | 7e-06 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.16 | 8e-06 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.16 | 9e-06 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.23 | 9e-06 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.13 | 1e-05 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.14 | 2e-05 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.14 | 2e-05 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.15 | 3e-05 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.15 | 3e-05 |